O-desulfated-heparin-inhalation (ParinGenix)

N/A

Report date: 2022/08/24 20:00:31
NME

Base Information

Drug NameO-desulfated-heparin-inhalation (ParinGenix)
Drug Alias NamePGX-200
ClassificationSmall molecules > Carbohydrate
Mechanisms of ActionCathepsin G inhibitorsP-selectin inhibitorsLeukocyte elastase inhibitors
TargetsCathepsin GLeukocyte elastaseP-selectin
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveAsthmaCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesParingenix
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesParingenix
Active IndicationsN/A
Inactive IndicationsPulmonary Disease, Chronic ObstructiveAsthmaCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A